Generation Net Income from 2010 to 2026

GBIO Stock  USD 5.34  0.00  0.00%   
Use the financial statements timeline for Generation Bio to frame performance drivers and balance sheet structure. Key drivers include key balance sheet drivers along with ratios such as core financial ratios. This view complements Generation Bio Valuation and Volatility modules.
Generation Bio has a market cap of 35.98 M, operating margin of -20.2%, ROE of -80.81%. Review Risk vs Return Analysis for broader portfolio context. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.

Pair Trading with Generation Bio

Pair trading with Generation Bio can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Moving against Generation Stock

  0.7HPQ HP IncPairCorr
  0.68MSFT MicrosoftPairCorr
  0.56AXP American ExpressPairCorr
  0.49JPM JPMorgan ChasePairCorr
  0.47BAC Bank of AmericaPairCorr
Finding correlated alternatives to Generation Bio is a practical necessity for tax-aware investors. The wash-sale rule prohibits repurchasing Generation Bio Co within 30 days of a loss sale, making it essential to identify substitute holdings with similar risk profiles.
The statistical relationship between Generation Bio and other instruments is summarized by the correlation coefficient. Investors use this measure to identify whether adding a new position would truly diversify a portfolio already containing Generation Bio.
Use Correlation analysis and pair trading evaluation for Generation Bio to review hedging context. The approach can be applied within sectors or across broader universes.
Pair CorrelationCorrelation Matching

More Resources for Generation Stock Analysis

Understanding Generation Bio typically begins with financial statements and long-term trend review. Ratio context helps frame profitability, efficiency, and growth trends for Generation Bio Co Stock. Outlined below are key reports that provide context for Generation Bio Co Stock:
Generation Bio has a market cap of 35.98 M, operating margin of -20.2%, ROE of -80.81%. Review Risk vs Return Analysis for broader portfolio context. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
Analysis related to Generation Bio should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Generation Bio's market price can diverge from book value, the accounting figure shown on Generation's balance sheet. Generation Bio's market capitalization is 35.98 M. A P/B ratio of 0.71 suggests Generation Bio trades near or below book value. Intrinsic value reflects what Generation Bio's fundamentals imply about worth, which may differ from both the trading price and the book figure. Analytical frameworks help reconcile those views.
It is useful to distinguish Generation Bio's value from its trading price, which are computed with different methods. For Generation Bio, key inputs include a P/B ratio of 0.71, ROE of -80.81%, and revenue of 19.89 M. The quoted price is simply the exchange level where supply meets demand.